CARsgen Therapeutics Holdings Limited (HKG:2171)

HKG:2171 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	39.43	-	-	25.81	-
Cost of Revenue	24.68	-	-	-	-
Gross Profit	14.75	-	-	25.81	-
Selling, General & Admin	162.84	133.31	136.61	126.52	77.61
Research & Development	463.74	660.04	679.49	501.03	281.03
Other Operating Expenses	139.91	-8.3	-10.45	-14.34	-9.98
Operating Expenses	766.49	785.05	805.65	613.21	348.67
Operating Income	-751.75	-785.05	-805.65	-587.4	-348.67
Interest Expense	-5.71	-4.66	-15.52	-10.87	-13.48
Interest & Investment Income	41.92	72.79	27.57	9.61	0.76
Currency Exchange Gain (Loss)	-82.24	-30.47	-97.35	7.45	21.62
Other Non Operating Income (Expenses)	-	-	-	-4,156	-724.29
Pretax Income	-797.79	-747.39	-890.95	-4,737	-1,064
Income Tax Expense	0.35	0.41	1.3	7.65	-
Net Income	-798.13	-747.79	-892.25	-4,744	-1,064
Net Income to Common	-798.13	-747.79	-892.25	-4,744	-1,064
Shares Outstanding (Basic)	553	556	552	387	198
Shares Outstanding (Diluted)	553	556	552	387	198
Shares Change (YoY)	-0.58%	0.82%	42.60%	95.23%	-
EPS (Basic)	-1.44	-1.34	-1.62	-12.26	-5.37
EPS (Diluted)	-1.44	-1.34	-1.62	-12.26	-5.37
Free Cash Flow	-427.69	-463.77	-778.45	-688.16	-312.88
Free Cash Flow Per Share	-0.77	-0.83	-1.41	-1.78	-1.58
Gross Margin	37.41%	-	-	100.00%	-
Operating Margin	-1906.78%	-	-	-2275.59%	-
Profit Margin	-2024.43%	-	-	-18379.97%	-
Free Cash Flow Margin	-1084.81%	-	-	-2665.95%	-
EBITDA	-686.61	-717.64	-748.73	-552.49	-316.4
D&A For EBITDA	65.14	67.41	56.92	34.91	32.27
EBIT	-751.75	-785.05	-805.65	-587.4	-348.67

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.